These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32705241)

  • 1. Paxillin knockdown suppresses metastasis and epithelial‑mesenchymal transition in colorectal cancer via the ERK signalling pathway.
    Wen L; Zhang X; Zhang J; Chen S; Ma Y; Hu J; Yue T; Wang J; Zhu J; Wu T; Wang X
    Oncol Rep; 2020 Sep; 44(3):1105-1115. PubMed ID: 32705241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
    Du C; Wang X; Zhang J; Liu X; Zhu J; Liu Y
    Oncol Rep; 2016 Jan; 35(1):409-17. PubMed ID: 26530439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer.
    Chen DL; Wang DS; Wu WJ; Zeng ZL; Luo HY; Qiu MZ; Ren C; Zhang DS; Wang ZQ; Wang FH; Li YH; Kang TB; Xu RH
    Carcinogenesis; 2013 Apr; 34(4):803-11. PubMed ID: 23275153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Paxillin Expression and Phosphorylation on Colorectal Cancer Prognosis and Metastasis.
    Zheng H; Tsunedomi R; Xu M; Zhang Y; Kishi H; Kobayashi S; Tomochika S; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Iida M; Ioka T; Nagano H
    Anticancer Res; 2024 Feb; 44(2):511-520. PubMed ID: 38307570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plastin 1 drives metastasis of colorectal cancer through the IQGAP1/Rac1/ERK pathway.
    Zhang T; Wang Z; Liu Y; Huo Y; Liu H; Xu C; Mao R; Zhu Y; Liu L; Wei D; Liu G; Pan B; Tang Y; Zhou Z; Yang C; Guo Y
    Cancer Sci; 2020 Aug; 111(8):2861-2871. PubMed ID: 32350953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAK, Src and p-Paxillin expression is decreased in liver metastasis of colorectal carcinoma patients.
    Mantonakis E; Giaginis C; Pikoulis E; Felekouras E; Patsouris E; Liakakos T; Papalampros E; Theocharis S
    J BUON; 2017; 22(5):1097-1106. PubMed ID: 29135089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.
    Wu DW; Wu TC; Wu JY; Cheng YW; Chen YC; Lee MC; Chen CY; Lee H
    Oncogene; 2014 Aug; 33(35):4385-95. PubMed ID: 24096476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.
    Su F; Wang BF; Zhang T; Hou XM; Feng MH
    Cancer Biomark; 2019; 26(4):451-460. PubMed ID: 31640089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
    Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X
    Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DUOX2 promotes the progression of colorectal cancer cells by regulating the AKT pathway and interacting with RPL3.
    Zhang X; Han J; Feng L; Zhi L; Jiang D; Yu B; Zhang Z; Gao B; Zhang C; Li M; Zhao L; Wang G
    Carcinogenesis; 2021 Feb; 42(1):105-117. PubMed ID: 32531052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
    Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
    Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spred2 inhibits epithelial‑mesenchymal transition of colorectal cancer cells by impairing ERK signaling.
    Wang H; Liu S; Kong F; Xiao F; Li Y; Wang H; Zhang S; Huang D; Wang L; Yang Y
    Oncol Rep; 2020 Jul; 44(1):174-184. PubMed ID: 32319644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR.
    Du F; Qiao C; Li X; Chen Z; Liu H; Wu S; Hu S; Qiu Z; Qian M; Tian D; Wu K; Fan D; Nie Y; Xia L
    Theranostics; 2019; 9(13):3879-3902. PubMed ID: 31281520
    [No Abstract]   [Full Text] [Related]  

  • 16. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
    Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
    J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic LIF reprograms invasive mode to enhance NPC dissemination through modulating YAP1-FAK/PXN signaling.
    Liu SC; Hsu T; Chang YS; Chung AK; Jiang SS; OuYang CN; Yuh CH; Hsueh C; Liu YP; Tsang NM
    Nat Commun; 2018 Nov; 9(1):5105. PubMed ID: 30504771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paxillin promotes colorectal tumor invasion and poor patient outcomes via ERK-mediated stabilization of Bcl-2 protein by phosphorylation at Serine 87.
    Huang CC; Wu DW; Lin PL; Lee H
    Oncotarget; 2015 Apr; 6(11):8698-708. PubMed ID: 25826088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
    Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
    Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
    Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.